Irach B. Taraporewala
Sitara Pharmaceutical Group, New York, USA
Biography
Irach B. Taraporewala is President of the Sitara Pharmaceutical Group. He is an innovator-serial entrepreneur; pharma executive, drug delivery & development expert provides consultant services for product development and strategy, Regulatory Affairs. Former CEO and President at OHR Pharmaceutical, he developed AVR118, a peptide immunomodulatory drug parenteral and topical formulations for cancer cachexia and squalamine eye drop formulations for treating retinal diseases, He has worked on drug-device combination devices for ophthalmic and intranasal drug delivery and development of molecular diagnostic products as well.
Abstract
Abstract : Modes of Topical and Localized Drug Delivery of Nanoparticle and Microparticle Based Formulations